CorMedix Inc. financial data

Symbol
CRMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Connell Drive, Suite 4200, Berkeley Heights, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 533 % -46.6%
Quick Ratio 29.9 %
Debt-to-equity 22.5 % +90.2%
Return On Equity -79.2 % -20%
Return On Assets -64.7 % -9.61%
Operating Margin -46.8K % -204%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.7M shares +10.7%
Common Stock, Shares, Outstanding 57.9M shares +5.61%
Entity Public Float 180M USD +9.82%
Common Stock, Value, Issued 57.9K USD +5.61%
Weighted Average Number of Shares Outstanding, Basic 58.8M shares +4.02%
Weighted Average Number of Shares Outstanding, Diluted 58.8M shares +4.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 11.5M USD
Cost of Revenue 687K USD
Research and Development Expense 4.5M USD -67.1%
Selling and Marketing Expense 6.75M USD +66.3%
General and Administrative Expense 6.58M USD +75.7%
Operating Income (Loss) -51M USD -22.3%
Nonoperating Income (Expense) 511K USD -29.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.78M USD +71.5%
Income Tax Expense (Benefit) -1.39M USD
Net Income (Loss) Attributable to Parent -46.1M USD -16%
Earnings Per Share, Basic -0.8 USD/shares +6.98%
Earnings Per Share, Diluted -0.8 USD/shares +6.98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.3M USD -33.8%
Accounts Receivable, after Allowance for Credit Loss, Current 17.4M USD
Inventory, Net 6.65M USD
Assets, Current 73.2M USD -17.9%
Property, Plant and Equipment, Net 1.9M USD +19.6%
Operating Lease, Right-of-Use Asset 531K USD -21.4%
Intangible Assets, Net (Excluding Goodwill) 1.9M USD
Assets 77.6M USD -15.1%
Accounts Payable, Current 1.34M USD -43.7%
Employee-related Liabilities, Current 1.79M USD +24.8%
Accrued Liabilities, Current 17M USD +230%
Liabilities, Current 18.5M USD +141%
Operating Lease, Liability, Noncurrent 393K USD -29.4%
Liabilities 18.9M USD +129%
Accumulated Other Comprehensive Income (Loss), Net of Tax 89.1K USD +5.59%
Retained Earnings (Accumulated Deficit) -353M USD -15%
Stockholders' Equity Attributable to Parent 58.7M USD -29.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 53.9M USD -9.92%
Liabilities and Equity 77.6M USD -15.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.3M USD -66.5%
Net Cash Provided by (Used in) Financing Activities -97.1K USD -101%
Net Cash Provided by (Used in) Investing Activities 8.94M USD
Common Stock, Shares Authorized 160M shares 0%
Common Stock, Shares, Issued 57.9M shares +5.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.46M USD +52.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.4M USD -33.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9.84K USD +12.1%
Deferred Tax Assets, Valuation Allowance 70.8M USD +22.5%
Deferred Tax Assets, Gross 70.8M USD +22.5%
Operating Lease, Liability 556K USD -20.9%
Depreciation 21.8K USD +29.4%
Payments to Acquire Property, Plant, and Equipment 61.3K USD +315%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.1M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid 639K USD -24.3%
Property, Plant and Equipment, Gross 1.87M USD +15.9%
Operating Lease, Liability, Current 163K USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 211K USD +1.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 208K USD +1.46%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 83K USD -41.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 169K USD -19.9%
Preferred Stock, Shares Issued 182K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 169K USD
Operating Lease, Payments 204K USD +2%
Additional Paid in Capital 412M USD +5.55%
Preferred Stock, Shares Outstanding 182K shares 0%
Share-based Payment Arrangement, Expense 68K USD +36%
Interest Expense 36.1K USD +12.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%